Ankit Agrawal is a global life sciences strategist with extensive experience in the Pharmaceutical & Private Equity Industry. He is a transformational leader with focused expertise in leading enterprise-wide initiatives to frame strategic decisions and generate value creation through operational excellence. With over ten years leading teams, Ankit has driven growth and enterprise strategy for clients with valuations of more than $20 billion. His has extensive international experience with assignments in EU5, Japan, Singapore, Switzerland, and Poland.

​

Ankit's breadth and depth of experience in corporate development, integration, operations, go-to-market processes, organizational transformation, and KPI driven solutions has led to significant consulting and industry-experience with roles at various private-equity backed organizations (up to $6 billion in AUM), Pharmaceutical & Life Science companies (valued at $50 billion) and strategy consulting firms such as Booz & Company and PwC.

​

Some of his notable achievements include the development of a product life cycle strategy for a mature brand product portfolio as the lead or key member of the team, resulting in a double-digit top-line growth of $1 billion in revenue annually. Creating a portfolio strategy for a top 10 oncology company, including an expansion blueprint for clinical and late-stage assets (novel-novel combinations) and identified a revenue of $5.7 billion over a five-to-seven-year period. And developed a cost optimization operating plan for a $100 billion biopharmaceutical company, resulting in $1.7 billion in savings across the enterprise (commercial, R&D, manufacturing) & identified reinvestment strategies for growth.

​

Ankit holds an Executive MBA from Northwestern University - Kellogg School of Management, a Master of Science in Health Care Policy & Management from Carnegie Mellon University, and a Bachelor of Science in Biotechnology.